Hansa Biopharma AB(SE:HNSA)
kr 46.84+0.56 (+1.21%)
SE:HNSA
Hansa Biopharma AB financials statements
kr 46.84
At close:+0.56 (+1.21%)
Want to see SE:HNSA full AI Analyst Report?
Hansa Biopharma AB (HNSA) Income Statement
18 Followers
Hansa Biopharma AB Income Statement
Last quarter (Q3 2026), Hansa Biopharma AB's total revenue was kr142.99M, an increase of 364.18% from the same quarter last year. In Q3, Hansa Biopharma AB's net income was kr-178.48M. See Hansa Biopharma AB’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| kr 222.26M | kr 171.32M | kr 134.09M | kr 154.53M | kr 33.88M | |
| kr 138.71M | kr 87.76M | kr 70.95M | kr 116.05M | kr 18.45M | |
| kr 659.42M | kr 725.64M | kr 859.45M | kr 692.17M | kr 558.03M | |
| Depreciation and Amortization | kr 38.76M | kr 28.06M | kr 19.79M | kr 12.05M | kr 8.61M |
| kr -483.82M | kr -642.07M | kr -705.50M | kr -554.26M | kr -538.83M | |
| kr -520.71M | kr -637.88M | kr -788.50M | kr -576.12M | kr -539.58M | |
| kr -9.27M | kr -166.33M | kr -42.32M | kr -33.86M | kr -1.15M | |
| kr -531.84M | kr -804.21M | kr -830.81M | kr -609.98M | kr -548.13M | |
| kr -534.11M | kr -807.24M | kr -831.72M | kr -611.13M | kr -548.28M | |
| Per Share Metrics | |||||
| Basic EPS | kr -6.52 | kr -12.84 | kr -15.83 | kr -13.60 | kr -12.33 |
| Diluted EPS | kr -6.52 | kr -12.84 | kr -15.83 | kr -13.60 | kr -12.33 |
| Weighted Average Shares Outstanding | 81.20M | 62.83M | 52.54M | 44.92M | 44.47M |
| Weighted Average Shares Outstanding (Diluted) | 81.20M | 62.83M | 52.54M | 44.92M | 44.47M |
Currency in SEK
